300254.SZ Stock Analysis
30
Uncovered
Shanxi C&Y Pharmaceutical Group Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Shanxi C&Y Pharmaceutical Group Co., Ltd. principally engages in the research, development, production, and sale of pharmaceuticals and supplements. The company is headquartered in Datong, Shanxi and currently employs 1,191 full-time employees. The company went IPO on 2011-08-19. The Company’s main products include anti-infective agents, respiratory system agents, cardiovascular drugs, antidepressant drugs, urinary system agents, pediatric agents and other drugs, as well as pharmaceutical raw materials and pharmaceutical intermediates. The company also involves in the manufacture and distribution of health food products, as well as the provision of deoxyribonucleic acid (DNA) genetic preservation and pregnant environment testing services. The firm distributes its products in domestic market.